Gabriel S. Morris
Chief Financial Officer, Immix Biopharma, Inc.
Companies
- Immix Biopharma, Inc.President May 29, 2026 to now1
- Immix Biopharma, Inc.Board member Dec 15, 2021 to now2
- Immix Biopharma, Inc.Chief financial officer Dec 15, 2021 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Immix Biopharma, Inc. IMMX315,570 shares3$2.6M at $8.26Dec 10, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 10, 2025Bought 770 shares at $6.58 of Immix Biopharma, Inc.3
- Dec 8, 2025Exercised 156,000 shares at $0.80 of Immix Biopharma, Inc.3
- Sep 16, 2025Bought 2,600 shares at $1.97 of Immix Biopharma, Inc.4
- Jun 18, 2025Bought 2,225 shares at $2.28 of Immix Biopharma, Inc.5
- Jun 7, 2024Bought 2,500 shares at $2.12 of Immix Biopharma, Inc.6
- Jun 4, 2024Bought 3,300 shares at $1.81 of Immix Biopharma, Inc.7
- May 20, 2024Granted 24,141 shares of Immix Biopharma, Inc.8
- May 20, 2024Granted 24,141 shares of Immix Biopharma, Inc.8
- May 20, 2024Granted 194,218 shares of Immix Biopharma, Inc.8
- May 14, 2024Bought 4,500 shares at $2.23 of Immix Biopharma, Inc.9
- Nov 14, 2022Bought 5,200 shares at $0.94 of Immix Biopharma, Inc.10
- Dec 20, 2021Bought 2,000 shares at $5.00 of Immix Biopharma, Inc.11
- Dec 20, 2021Converted 123,176 shares at $0.85 of Immix Biopharma, Inc.11
- Dec 20, 2021Converted 123,527 shares at $0.85 of Immix Biopharma, Inc.11
- Dec 20, 2021Converted 74,116 shares at $0.85 of Immix Biopharma, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARImmix Biopharma, Inc., President
- 2SEC EDGARImmix Biopharma, Inc., Board member
- 3
- 4SEC EDGARForm 4 filed Sep 17, 2025
- 5SEC EDGARForm 4 filed Jun 20, 2025
- 6SEC EDGARForm 4 filed Jun 10, 2024
- 7SEC EDGARForm 4 filed Jun 5, 2024
- 8SEC EDGARForm 4 filed May 20, 2024
- 9SEC EDGARForm 4 filed May 14, 2024
- 10SEC EDGARForm 4 filed Nov 15, 2022
- 11SEC EDGARForm 4 filed Dec 20, 2021